Efficacy and safety of angiogenesis inhibitors in small-cell lung cancer

OBJECTIVE: The purpose of this study was to investigate the efficacy and safety of angiogenesis inhibitors for small-cell lung cancer (SCLC). METHODS: Totally, 16 controlled trials (1898 cases) involving angiogenesis inhibitors plus chemotherapy (ACT group) versus chemotherapy alone group (CT group)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Heng, Li, Lina, Luo, Shuimei, Zhou, Sijing, Shen, Ruifen, Yang, Haitao, Chen, Huijuan, Xie, Xianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352042/
https://www.ncbi.nlm.nih.gov/pubmed/27901478
http://dx.doi.org/10.18632/oncotarget.13588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352042/
https://www.ncbi.nlm.nih.gov/pubmed/27901478
http://dx.doi.org/10.18632/oncotarget.13588

Ejemplares similares